Image
ACR Convergence 2024 (American College of Rheumatology)
November 14th-19th 2024
Committed to finding answers in rheumatology
Washington, D.C. | Nov. 14-19 | Booth 2318
More than 50 years of experience in rheumatology testing and protocols
Join us at ACR Convergence 2024 to learn more about our leading rheumatology services, listen in to a Lightning Talk on anti-DFS70 antibodies, and view our latest posters on rheumatoid arthritis testing patterns and therapeutic drug monitoring of the adalimumab biosimilar adalimumab-atto.
Saturday, Nov. 16, 2024 | 10:30 AM-12:30 PM ET | Poster Session A
0158: Rheumatoid Arthritis Testing Patterns by Physicians and Advanced Practice Providers from a National Commercial Laboratory, 2014 – 2023
Karis Lee, Min Kyung Lee, David Alfego, Kristen Clark, Stanley Naides
Meet author: Karis Lee, MSN, FNP-C
Saturday, Nov. 16, 2024 | 10:30 AM-12:30 PM ET | Poster Session A
0465: Therapeutic Drug Monitoring of the Adalimumab Biosimilar (AMJEVITA™, Adalimumab-atto) Using Originator Adalimumab and Anti-Adalimumab Antibody Assays
Monique Bastidas, Lythou Yeo, Susie Magpantay, Judah Scott, Mike Zikry, Wayne Galdamez, Jane Yang, Kelly Chun
Meet presenter: Rubio Punzalan, MD, PhD
Sunday, Nov. 17, 2024 | 11:47 AM ET | Booth 3257 Wifi Way
Lightning Talk: The Clinical Relevance of Anti-DFS70 Autoantibodies
A novel marker that may help identify individuals who do not have an ANA-associated autoimmune rheumatic disease especially in the absence of significant clinical findings
Meet speaker: Vincent Ricchiuti, PhD